993 resultados para 330.07
Resumo:
Sem medir o tempo não teria feito sentido falar-se, como tanto se falou na indústiia desde finais do século passado, pelo menos', em organização racional, ou científica, do trabalho. Foi empunhando o cronômetio que Frederick Winslow Taylor (1856-1915) observou as práticas de trabalho, experimentou e estabeleceu seqüências "racionais". Contando tempos, demonstrou a eficácia quantitativa da segmentação das tarefas e depuração dos gestos técnicos até ao estritamente necessário, com exclusão de todo o "desperdício" gestual susceptível de gerar lentidão ou atraso (Left-anc, 1975: 330-31; SainsauUeu, 1985: 374-76; Freire, 1993: 63-67, por exemplo).
Resumo:
Dissertação para obtenção de Grau de Mestre em Microbiologia Médica pela Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa
Resumo:
The problem to be discussed results from the relationship established between the insurer and insured by the conclusion of an insurance contract, namely an optional liability insurance contract, to cover the risks taken by the insured resulting from the occurrence of a claim, such as those arising from the emergence of the liability and consequent obligation to compensate damages caused to a third party. This thesis concerns thus the debate between those who consider that, in the optional insurance, the third party may require compliance with the provision to both the insured and the insurer (in the case of voluntary joinder, pursuant to Art. 27 CCP, which corresponds Art. 32 of the New Code of Civil Procedure, Law n. 41/2013 of 26 June, which entered into force on 1 September, hereinafter New Code) - insurance contract on behalf of a third party conception - in the same way that the insured defendant can bring the insurer to intervene as co-defendant in the main process, pursuant al. a) of art. 325 of the CCP (corresponding to art. 316 of the New Code - main intervention caused), and those who argue that the insurer may only intervene in the action as an ancillary party, to assist the defendant, lacking interest, therefore, in necessary or volunteer joinder, with the consequence that the insurer cannot be sued as a main party - only ancillary intervention is justifiable (cf. art. 330 CPC, which corresponds to art. 321 of the New Code).
Resumo:
3rd ed.
Resumo:
ii. Desprès de finalitzar el primer any d’aplicació del projecte “La música a les Escoles Bressol Municipals de Mataró”, s’inicia la present recerca, en la que participen tots els grups que formen part del projecte, amb l’objectiu de valorar-ho i veure’n la continuïtat. Es detecta que els materials emprats en la proposta didàctica són l’element que ha esdevingut més exitós fins al moment. Definint-ne una mostra de set materials, es procedeix a determinar l’ús que les educadores els atorguen en relació a la proposta didàctica i a avaluar-los
Resumo:
BACKGROUND: We conducted a randomized, phase II, multicenter study to evaluate the anti-epidermal growth factor receptor (EGFR) mAb panitumumab (P) in combination with chemoradiotherapy (CRT) with standard-dose capecitabine as neoadjuvant treatment for wild-type KRAS locally advanced rectal cancer (LARC). PATIENTS AND METHODS: Patients with wild-type KRAS, T3-4 and/or N+ LARC were randomly assigned to receive CRT with or without P (6 mg/kg). The primary end-point was pathological near-complete or complete tumor response (pNC/CR), defined as grade 3 (pNCR) or 4 (pCR) histological regression by Dworak classification (DC). RESULTS: Forty of 68 patients were randomly assigned to P + CRT and 28 to CRT. pNC/CR was achieved in 21 patients (53%) treated with P + CRT [95% confidence interval (CI) 36%-69%] versus 9 patients (32%) treated with CRT alone (95% CI: 16%-52%). pCR was achieved in 4 (10%) and 5 (18%) patients, and pNCR in 17 (43%) and 4 (14%) patients. In immunohistochemical analysis, most DC 3 cells were not apoptotic. The most common grade ≥3 toxic effects in the P + CRT/CRT arm were diarrhea (10%/6%) and anastomotic leakage (15%/4%). CONCLUSIONS: The addition of panitumumab to neoadjuvant CRT in patients with KRAS wild-type LARC resulted in a high pNC/CR rate, mostly grade 3 DC. The results of both treatment arms exceeded prespecified thresholds. The addition of panitumumab increased toxicity.
Resumo:
NORTH SEA STUDY OCCASIONAL PAPER No. 120
Resumo:
BACKGROUND: Oral temozolomide has shown similar efficacy to dacarbazine in phase III trials with median progression-free survival (PFS) of 2.1 months. Bevacizumab has an inhibitory effect on the proliferation of melanoma and sprouting endothelial cells. We evaluated the addition of bevacizumab to temozolomide to improve efficacy in stage IV melanoma. PATIENTS AND METHODS: Previously untreated metastatic melanoma patients with Eastern Cooperative Oncology Group performance status of two or more were treated with temozolomide 150 mg/m(2) days 1-7 orally and bevacizumab 10 mg/kg body weight i.v. day 1 every 2 weeks until disease progression or unacceptable toxicity. The primary end point was disease stabilisation rate [complete response (CR), partial response (PR) or stable disease (SD)] at week 12 (DSR12); secondary end points were best overall response, PFS, overall survival (OS) and adverse events. RESULTS: Sixty-two patients (median age 59 years) enrolled at nine Swiss centres. DSR12 was 52% (PR: 10 patients and SD: 22 patients). Confirmed overall response rate was 16.1% (CR: 1 patient and PR: 9 patients). Median PFS and OS were 4.2 and 9.6 months. OS (12.0 versus 9.2 months; P = 0.014) was higher in BRAF V600E wild-type patients. CONCLUSIONS: The primary end point was surpassed showing promising activity of this bevacizumab/temozolomide combination with a favourable toxicity profile. Response and OS were significantly higher in BRAF wild-type patients.
Resumo:
DAO (DFP) 01/14 - Audit Of Grants To Local Government Bodies
Resumo:
El riu Canaletes va resultar afectat per l’ incendi que es va produir a Horta de Sant Joan el juliol de l’any 2009. El foc va malmetre bona part de la flora i fauna de la zona, però un dels ecosistemes que en va sortir més perjudicat va ser el del bosc de ribera, ecosistema molt fràgil en front de pertorbacions d’aquest tipus, ja que la seva capacitat de regeneració no és tant senzilla ni ràpida com en altres ecosistemes mediterranis com podrien ser els boscos de pi blanc. No obstant, si que existeixen algunes espècies de ribera que presenten una ràpida resposta als incendis com és el cas dels salzes o alguns pollancres o àlbers, que en aquest cas, poc temps després del foc ja presentaven rebrots, segons observacions realitzades al camp. Per comprovar l’evolució de la recuperació del bosc de ribera en la zona afectada per l’incendi, es van realitzar diverses sortides de camp. D’aquestes observacions, es va poder deduir que actualment el bosc de ribera de la zona estudiada, evoluciona segons les previsions realitzades en estudis immediatament posteriors al foc, de manera que hi estan proliferant de manera ràpida bardisses amb esbarzer, gavarrera, roldor i sanguinyol, en aquells llocs que abans de l’incendi eren ocupats per arbres caducifolis.
Resumo:
Financial support arrangements in the 2007/08 academic year for Allied Health Professional Students and Medical and Dental students from year five study
Resumo:
Glossary of Terms to the Strategic Resources Framework Report 2006/07
Resumo:
This handbook was published in conjunction with the 4 Area Child Protection Committees
Resumo:
The National Child Measurement Programme (NCMP) weighs and measures children in Reception (typically aged 4 - 5 years) and (aged 10 - 11 years) annually. The report highlights the usefulness of the NCMP Dataset in furthering our understanding of underweight, overweight and obesity in children, as well as highlighting some areas where improvements can be made in the programme, or where further analysis and investigation is required. The purpose of this report is not to provide specific local results, but an understanding from national-level analysis that can be used to inform local uses and analysis of NCMP data.